Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial

(2013) Ivanka Galeva et al.   CURRENT MEDICAL RESEARCH AND OPINION

72 Inspiratory flow characteristics of the T-326 dry powder inhaler (DPI) in CF patients

(2013) D. Geller et al.   Journal of Cystic Fibrosis

68 Comparison of pharmacy prescription refill frequency in CF adults before and after switching from tobramycin inhalation solution (TIS) to TOBI Podhaler – ‘Real world’ evidence of improved adherence

(2013) E.F. Nash et al.   Journal of Cystic Fibrosis

74 Improved tolerability, adherence and reduced intravenous (IV) antibiotic usage in CF patients receiving inhaled versus nebulised antibiotic prophylaxis. A real world comparison of tobramycin inhaled powder (TIP) and tobramycin inhaled solution (TIS)

(2013) M.J. Harrison et al.   Journal of Cystic Fibrosis

In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients

(2012) Ana Fernández-Olmos et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Sputum Tobramycin Concentrations in Cystic Fibrosis Patients with Repeated Administration of Inhaled Tobramycin

(2012) Jennifer Ruddy et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis

(2012) Antoine Regnault et al.   Journal of Cystic Fibrosis

A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis

(2012) Kavi J. Littlewood et al.   Journal of Cystic Fibrosis

Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis

(2012) Clement L. Ren et al.   Journal of Cystic Fibrosis

Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa

(2012) Petra Schelstraete et al.   Journal of Cystic Fibrosis

Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis

(2011) Niels Høiby   BMC Medicine

Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology

(2011) David E. Geller et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

323 Association of treatment satisfaction and compliance of cystic fibrosis (CF) patients using inhaled tobramycin treatment in the EAGER study

(2011) A. Regnault et al.   Journal of Cystic Fibrosis

Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution

(2011) Gregory S. Sawicki et al.   PEDIATRIC PULMONOLOGY

Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent?

(2011) David Lo et al.   RESPIRATORY MEDICINE

Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronicPseudomonas aeruginosainfection in cystic fibrosis

(2011) Michael D Parkins et al.   Expert Review of Respiratory Medicine

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

(2010) Michael W. Konstan et al.   Journal of Cystic Fibrosis

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial

(2010) Michael W. Konstan et al.   PEDIATRIC PULMONOLOGY

New Antimicrobial Strategies in Cystic Fibrosis

(2010) Mireille van Westreenen et al.   PEDIATRIC DRUGS

Emerging therapies in cystic fibrosis

(2010) Paula Anderson   Therapeutic Advances in Respiratory Disease

Emerging Treatments in Cystic Fibrosis

(2009) Andrew M. Jones et al.   DRUGS

Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review

(2009) Felix Ratjen et al.   Journal of Cystic Fibrosis

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

(2009) Harry Heijerman et al.   Journal of Cystic Fibrosis

Aerosol Antibiotics in Cystic Fibrosis

(2009) David E Geller   Respiratory Care

The prevalence of cystic fibrosis in the European Union

(2008) Philip M. Farrell   Journal of Cystic Fibrosis

High treatment burden in adults with cystic fibrosis: Challenges to disease self-management

(2008) Gregory S. Sawicki et al.   Journal of Cystic Fibrosis